Metabolix (MBLX) Reports Q2 Loss of $0.26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Metabolix Announces Second Quarter 2015 Financial Results
August 12, 2015 4:05 PM EDTCAMBRIDGE, Mass., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ: MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today reported financial results for the three months ended June 30, 2015.
"In June, we raised $15 million in a private placement that strengthens our balance sheet," said Joseph Shaulson, president and CEO of Metabolix. "We are using this capital to continue executing our business plan with a particular focus on converting commercial development opportunities to recurring sales of Mirel® specialty biopolymers.
"We have now completed the capital expansion of our pilot... More
